Clinical cardiac regenerative studies in children

Area of Science:

• Regenerative Medicine
• Pediatric Cardiology
• Stem Cell Therapy

Background:

• Pediatric heart failure, though rare, carries a high mortality rate and severe symptoms.
• Neonatal hearts possess greater cardiac progenitor cell capacity, indicating regenerative potential.
• There is growing interest in cardiac regeneration therapy for critically ill children.

Purpose of the Study:

• To review existing literature and ongoing studies on pediatric cardiac regeneration.
• To explore the application and outcomes of cell-based therapies in pediatric heart failure.

Main Methods:

• Literature search of MEDLINE, Google Scholar, and EMBASE for completed studies.
• Review of ongoing studies from www.clinicaltrials.gov.
• Analysis of case reports and cohort studies due to challenges in pediatric clinical trials.

Main Results:

• Most pediatric autologous cell transplantations target severe or terminal heart failure.
• Congenital heart disease, myocarditis, and cardiomyopathies are key areas for regenerative therapy.
• Intracoronary or intramyocardial administration of autologous cells (bone marrow mononuclear cells, progenitor cells, cardiospheres) showed clinical benefits.

Conclusions:

• Autologous stem cell administration, used compassionately, has demonstrated short-term benefits.
• Improvements in heart function and clinical stability were observed in most critically ill pediatric patients.
• Pediatric regenerative cardiology holds potential for treating severe heart conditions in children.